Glutamate dysfunction in first episode psychosis and relationship with the response to treatment
Abnormal glutamatergic neurotransmission is strongly implicated in the pathophysiology of schizophrenia. The main technique available for assessing central glutamate function in man in vivo is proton magnetic resonance spectroscopy (1H-MRS), which can be used to measure glutamate, its metabolite glu...
Main Author: | Merritt, Kate Sky |
---|---|
Other Authors: | McGuire, Philip ; Taylor, Matthew John ; Egerton, Alice |
Published: |
King's College London (University of London)
2016
|
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.754878 |
Similar Items
-
Relationship between glutamate dysfunction and symptoms and cognitive function in psychosis
by: Kate eMerritt, et al.
Published: (2013-11-01) -
Reduced Mismatch Negativity is Associated with Increased Plasma Level of Glutamate in First-episode Psychosis
by: Tatsuya Nagai, et al.
Published: (2017-05-01) -
First-episode psychosis: An update
by: Bonga Chiliza, et al.
Published: (2008-03-01) -
Family Intervention in First-Episode Psychosis
by: Anvar Sadath, et al.
Published: (2015-11-01) -
Prognostic models in first-episode psychosis
by: Daniel Whiting, et al.
Published: (2020-02-01)